124 related articles for article (PubMed ID: 7580266)
1. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.
Utech CI; Khatibnia U; Winter PF; Wulle KG
Thyroid; 1995 Jun; 5(3):185-93. PubMed ID: 7580266
[TBL] [Abstract][Full Text] [Related]
2. Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements.
Ohnishi T; Noguchi S; Murakami N; Tajiri J; Harao M; Kawamoto H; Hoshi H; Jinnouchi S; Futami S; Nagamachi S
Radiology; 1994 Mar; 190(3):857-62. PubMed ID: 8115640
[TBL] [Abstract][Full Text] [Related]
3. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
Nagy EV; Toth J; Kaldi I; Damjanovich J; Mezosi E; Lenkey A; Toth L; Szabo J; Karanyi Z; Leovey A
Eur J Endocrinol; 2000 Jun; 142(6):591-7. PubMed ID: 10832104
[TBL] [Abstract][Full Text] [Related]
4. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
Pauleit D; Schüller H; Textor J; Leutner C; Keller E; Sommer T; Träber F; Block W; Boldt I; Schild H
Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy.
Prummel MF; Gerding MN; Zonneveld FW; Wiersinga WM
Clin Endocrinol (Oxf); 2001 Feb; 54(2):205-9. PubMed ID: 11207635
[TBL] [Abstract][Full Text] [Related]
6. [The course of the disease in endocrine orbitopathy. Magnetic resonance tomographic documentation].
Hosten N; Schörner W; Lietz A; Wenzel KW
Rofo; 1992 Sep; 157(3):210-4. PubMed ID: 1391813
[TBL] [Abstract][Full Text] [Related]
7. Graves ophthalmopathy: MR imaging of the orbits.
Hosten N; Sander B; Cordes M; Schubert CJ; Schörner W; Felix R
Radiology; 1989 Sep; 172(3):759-62. PubMed ID: 2772184
[TBL] [Abstract][Full Text] [Related]
8. [Results of nuclear magnetic resonance tomography studies in endocrine orbitopathy].
Pedrosa P; Pfannenstiel P; Just M; Higer HP; Utech C; Brederhoff J; Wulle KG
Klin Monbl Augenheilkd; 1988 Aug; 193(2):169-73. PubMed ID: 3184751
[TBL] [Abstract][Full Text] [Related]
9. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.
Bartalena L; Marcocci C; Chiovato L; Laddaga M; Lepri G; Andreani D; Cavallacci G; Baschieri L; Pinchera A
J Clin Endocrinol Metab; 1983 Jun; 56(6):1139-44. PubMed ID: 6341388
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of extraocular muscles in Graves' ophthalmopathy using T1 mapping.
Zhu H; Zou M; Wu D; Li B; Su Y; Li Y; Hong S; Yang Z
Eur Radiol; 2023 Dec; 33(12):9074-9083. PubMed ID: 37466707
[TBL] [Abstract][Full Text] [Related]
11. [Prediction for effectiveness of steroid pulse therapy by MRI in Graves' ophthalmopathy].
Sato M; Hiromatsu Y; Tanaka K; Nonaka K; Kojima K; Nishimura H; Nishida H
Nihon Naibunpi Gakkai Zasshi; 1992 Mar; 68(3):143-53. PubMed ID: 1582520
[TBL] [Abstract][Full Text] [Related]
12. The use of real-time orbital ultrasound in Graves' ophthalmopathy: a comparison with computed tomography.
Given-Wilson R; Pope RM; Michell MJ; Cannon R; McGregor AM
Br J Radiol; 1989 Aug; 62(740):705-9. PubMed ID: 2670033
[TBL] [Abstract][Full Text] [Related]
13. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance.
Villadolid MC; Yokoyama N; Izumi M; Nishikawa T; Kimura H; Ashizawa K; Kiriyama T; Uetani M; Nagataki S
J Clin Endocrinol Metab; 1995 Sep; 80(9):2830-3. PubMed ID: 7673432
[TBL] [Abstract][Full Text] [Related]
14. [Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy].
Rodríguez-González N; Pérez-Rico C; López-Para Giménez R; Arévalo-Serrano J; Del Amo García B; Calzada Domingo L; Flores Ruiz L; Blanco R
Arch Soc Esp Oftalmol; 2011 Nov; 86(11):351-7. PubMed ID: 22040641
[TBL] [Abstract][Full Text] [Related]
15. Upgaze intraocular pressure changes and strabismus in Graves' ophthalmopathy.
Fishman DR; Benes SC
J Clin Neuroophthalmol; 1991 Sep; 11(3):162-5. PubMed ID: 1836798
[TBL] [Abstract][Full Text] [Related]
16. MRI measurements of orbital tissues in dysthyroid ophthalmopathy.
Nishida Y; Tian S; Isberg B; Tallstedt L; Lennerstrand G
Graefes Arch Clin Exp Ophthalmol; 2001 Nov; 239(11):824-31. PubMed ID: 11789862
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of extraocular muscle with high-field magnetic resonance in patients with Graves' ophthalmopathy with upper-lid retraction.
Chen Y; Jin ZY; Zhang ZH; Xu DD; Meng W; Jiang B; Fang HY; Sun ZY; Chen Y; Sun HY; Feng F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):461-7. PubMed ID: 23134821
[TBL] [Abstract][Full Text] [Related]
18. Graves ophthalmopathy: role of MR imaging in radiation therapy.
Just M; Kahaly G; Higer HP; Rösler HP; Kutzner J; Beyer J; Thelen M
Radiology; 1991 Apr; 179(1):187-90. PubMed ID: 2006276
[TBL] [Abstract][Full Text] [Related]
19. [Magnetic resonance tomographic differentiation of ocular muscle changes in endocrine orbitopathy].
Hosten N; Cordes M; Sander B; Schörner W; Wenzel KW; Felix R
Rofo; 1990 Apr; 152(4):388-92. PubMed ID: 2160096
[TBL] [Abstract][Full Text] [Related]
20. Role of octreoscan and correlation with MR imaging in Graves' ophthalmopathy.
Kahaly G; Diaz M; Just M; Beyer J; Lieb W
Thyroid; 1995 Apr; 5(2):107-11. PubMed ID: 7647569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
